Hang Tai Yue Group Holdings Ltd operates in the Medical laboratories sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hang Tai Yue Group Holdings Ltd with three other
pharmaceutical manufacturers in Asia:
sales of 1.73 billion Taiwanese Dollars [US$57.71 million]
of which 52%
was Sale of Precision Medical Equipment),
Medical & Biological Laboratories Company Limited
(7.07 billion Japanese Yen [US$64.21 million]
of which 99%
was Reagent business), and
Thyrocare Technologies Ltd
based in India
(3.56 billion Indian Rupees [US$50.13 million]
of which 92%
was Diagnostic Testing Services).
Hang Tai Yue Group Holdings Ltd reported sales of HK$471.48 million (US$60.69 million)
December of 2018.
increase of 16.5%
versus 2017, when the company's sales were HK$404.74 million.
Despite this increase, sales are still
below the level achieved in 2016, when Hang Tai Yue Group Holdings Ltd
reported sales of HK$510.14 million.